MAP2K5 and type 2 diabetes mellitus: Regarding G2 versus G1, which evaluated the influence of the glycemic control in patients with T2D, the genes AGBL5 (p = 0.043), CCDN3 (p = 0.0003), CEBPD (p < 0.0001), VAMP2 (p = 0.0001), ENO2 (p < 0.0001), and MAP2K5 (p = 0.027) were significantly upregulated in the G2 subjects compared to the G1 subjects (Figure 1(b)).